Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)
Small Molecules Studied
Download: Excel (XLSX), Comma-separated (CSV), Images (Zip file)
HMS LINCS ID | Name | Alternative Names | LINCS ID | Structure Image | PubChem CID |
---|---|---|---|---|---|
10239-1 | AG1024 | Tyrphostin AG 1024 | LSM-4262 | 2044 | |
10241-4 | Bortezomib | Velcade | LSM-6281 | 387447 | |
10241-1 | Bortezomib | Velcade | LSM-6281 | 387447 | |
10511-1 | Mebendazole | Vermox | 4030 | ||
10513-1 | Nelfinavir | Viracept | 64143 | ||
10021-5 | Tozasertib | VX680; MK-0457 | LSM-1021 | 5494449 | |
10098-2 | Gefitinib | ZD1839; Iressa | LSM-1098 | 123631 |